Spots Global Cancer Trial Database for Myoma Microvascularization Analysis Using Sonovue Before and After Uterine Artery Embolization

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Myoma Microvascularization Analysis Using Sonovue Before and After Uterine Artery Embolization

Official Title: Myoma Microvascularization Analysis Using Sonovue Before and After Uterine Artery Embolization

Study ID: NCT00351494

Conditions

Myoma

Interventions

contrast enhanced ultrasonography

embolization

Study Description

Brief Summary: Contrast-enhanced ultrasound is supposed to improve the detection of myomas as well as improve the follow-up after specific treatments like embolization. It will also help the investigators better understand the mechanism of success or failure for embolization and could reduce the amount of particles injected by determining the endpoint of the procedure in order to treat the myomas while preserving the myometrium.

Detailed Description: Before embolization of the uterine artery, 40 patients with unique or multiple myomas will be included prospectively in our study and evaluated with sonography before and after injection of Sonovue (2.4 ml) (Bracco Int Milano Italy). Pelvic ultrasound with contrast enhancement will be done the day after and six months after the procedure. Microvascularization of the myomas and the endometrium will be described. Some tiny myomas which are not visible on conventional sonography could be identified for a perfect matching with MRI detection.